Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
10%
Ph phase_2
2
20%
Ph phase_4
1
10%
Ph not_applicable
5
50%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(5)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Recruiting3
Completed2
unknown1
Suspended1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

unknown110%
suspended110%
completed220%
not_yet_recruiting110%
active_not_recruiting110%
withdrawn110%
recruiting330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10